A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

NCT07136142 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor

Interventions

DRUG: FH-006 for Injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.